| Predicate |
Object |
| contentType |
Comparative Study|Journal Article |
| endingPage |
30 |
| issn |
0025-732X |
| issueIdentifier |
1101 |
| pageRange |
29-30 |
| publicationName |
The Medical letter on drugs and therapeutics |
| startingPage |
29 |
| bibliographicCitation |
Nateglinide for type 2 diabetes. Med Lett Drugs Ther. 2001 Apr 02;43(1101):29–30. PMID: 11283474. |
| date |
2001-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/11283474 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5635
https://portal.issn.org/resource/ISSN/0025-732X |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Nateglinide for type 2 diabetes |
| discusses |
http://id.nlm.nih.gov/mesh/M0353981
http://id.nlm.nih.gov/mesh/M0005469
http://id.nlm.nih.gov/mesh/M0016544
http://id.nlm.nih.gov/mesh/M0013535 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D003924Q000188
http://id.nlm.nih.gov/mesh/D010649Q000627
http://id.nlm.nih.gov/mesh/D003510Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D003510Q000494
http://id.nlm.nih.gov/mesh/D008687Q000627
http://id.nlm.nih.gov/mesh/D003510Q000008
http://id.nlm.nih.gov/mesh/D000284
http://id.nlm.nih.gov/mesh/D010649Q000008
http://id.nlm.nih.gov/mesh/D000077715
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004244Q000139
http://id.nlm.nih.gov/mesh/D010649Q000031
http://id.nlm.nih.gov/mesh/D010649Q000494 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311309 |